PLATFORMS: Injection Devices

Reusable Needle-Free Injectors (Medi-Jector VISION®)

deliver precise medication doses through high-speed, pressurized liquid penetration of the skin without a needle. These reusable, variable-dose devices are engineered to last for a minimum of two years and are designed for easy use, facilitating self-injection with a disposable plastic needle-free syringe to assure safety and efficacy. The associated disposable plastic needle-free syringe, offers high precision liquid medication delivery through an opening that is approximately half the diameter of a standard, 30-gauge needle and it is designed to last for approximately one week. Antares has sold the Medi-Jector VISION® for use in more than 30 countries to deliver either insulin or human growth hormone (“hGH”).

click on image to view enlarged version

Disposable Mini-Needle Injectors (Vibex™)

employ the same core technology developed for the Medi-Jector VISION®, utilizing a coil-spring power source to rapidly deliver the medication. This is combined with a tiny hidden needle in a disposable, single-use injection system compatible with conventional syringes. The Vibex™ system is designed to economically provide highly reliable subcutaneous injections with reduced discomfort and improved convenience in conjunction with the enhanced safety of an integrated shielded needle. After use, the device can be disposed of without the typical “sharps” disposal concerns. Antares and its development partners have successfully tested the device in patient preference and bioavailability tests with a variety of injectable drugs. Antares continues to explore product extensions including multiple dose and variable dose applications as well as integrated reconstitution systems for lyophilized drugs.

click on image to view enlarged version
 

Vaccine Intradermal Injectors

are a variation of the Vibex™ disposable mini-needle injection system and are being developed to deliver vaccines into the dermal and subdermal layers of the skin (a preferred site of administration in the vaccine industry). The Company believes that this proprietary device will offer easier, more accurate and more rapid dosing compared with conventional needle-based devices.